Persistent Rheumatoid Arthritis Symptoms Linked to Depression and Sleep Disorders
Researchers at Semmelweis University have identified that persistent symptoms in rheumatoid arthritis may be driven by factors beyond just inflammation. This chronic autoimmune disease, which affects many individuals in Hungary, leads to pain, swelling, and stiffness in the joints. While most patients respond well to treatment, a significant percentage, estimated between 6-28%, fall into a category known as "difficult-to-treat" due to their ongoing symptoms despite therapy. The studies published in Nature Reviews Rheumatology and The Lancet Rheumatology highlight that health issues such as sleep disorders, depression, obesity, and smoking may not only coexist with rheumatoid arthritis but could also play a role in sustaining its symptoms.
A notable finding from the research is the interplay between pain, mood, and sleep. For instance, pain and depression can reduce physical activity, leading to weight gain and exacerbating both sleep quality and mood. This creates a challenging cycle that can be hard to break. The researchers have developed a new model that aims to improve the management of patients with rheumatoid arthritis who find their condition difficult to control. Traditionally, the "treat-to-target" approach focuses on measurable indicators of disease activity, adjusting treatment if inflammation does not decrease sufficiently.
However, the researchers suggest that when inflammation markers improve but patients continue to experience pain and fatigue, it is crucial for healthcare providers to investigate other potential causes. Dr. György Nagy, head of the Department of Rheumatology and Immunology at Semmelweis University, emphasizes the importance of identifying whether chronic pain syndromes, depression, sleep disorders, or obesity are contributing to the ongoing symptoms. This approach not only aims to enhance patient outcomes but also strengthens the relationship between doctors and patients by focusing treatment on the actual drivers of symptoms.
The model proposed by the Semmelweis University team has gained international recognition, with their work on "difficult-to-treat" rheumatoid arthritis being cited over a thousand times. This definition is now being applied not only to rheumatoid arthritis but also in discussions surrounding other diseases.
Looking ahead, the researchers plan to leverage artificial intelligence to further enhance treatment personalization for rheumatoid arthritis patients. Dr. Lilla Gunkl-Tóth, a PhD student involved in the research, explains that AI could help identify patient subgroups and develop tailored treatment strategies based on these insights. This innovative approach aims to improve the quality of life for those affected by rheumatoid arthritis, addressing the complex interplay of symptoms that can persist even when inflammation is under control.




